Drug-associated changes in amino acid residues in Gag p2, p7NC, and p6Gag/p6Pol in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response

被引：26

作者：

Ho, Sarah K. ^{[1
]}

Coman, Roxana M. ^{[1
]}

Bunger, Joshua C. ^{[1
]}

Rose, Stephanie L. ^{[1
]}

O'Brien, Patricia ^{[1
]}

Munoz, Isabel ^{[1
]}

Dunn, Ben M. ^{[2
]}

Sleasman, John W. ^{[3
,4
]}

Goodenow, Maureen M. ^{[1
]}

机构：

[1] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32601 USA

[2] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32601 USA

[3] Univ S Florida, Dept Pediat, Div Allergy Immunol & Rheumatol, Tampa, FL 33620 USA

[4] Univ S Florida, All Childrens Hosp, St Petersburg, FL 33701 USA

来源：

VIROLOGY | 2008年 / 378卷 / 02期

关键词：

fitness; protease; Pi resistance;

D O I：

10.1016/j.virol.2008.05.029

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Regions of HIV-1 gag between p2 and p6(Gag)/p6(Pol), in addition to protease (PR), develop genetic diversity in HIV-1 infected individuals who fail to suppress virus replication by combination protease inhibitor (PI) therapy. To elucidate functional consequences for Viral replication and PI susceptibility by changes in Gag that evolve in vivo during PI therapy, a panel Of recombinant viruses was constructed. Residues in Gag p2/p7(NC) cleavage site and p7(NC), combined with residues in the flap of PR, defined novel fitness determinants that restored replicative capacity to the posttherapy Virus. Multiple determinants in Gag have a dominant effect on PR phenotype and increase susceptibility to inhibitors of drug-resistant or drug-sensitive PR genes. Gag determinants of drug sensitivity and replication alter the fitness landscape of the virus, and viral replicative capacity can be independent of drug sensitivity. The functional linkage between Gag and PR provides targets for novel therapeutics to inhibit drug-resistant viruses. (C) 2008 Elsevier Inc. All rights reserved.

引用

页码：272 / 281

页数：10

共 76 条

[1] HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT [J].

Andersen, Joshua L. ;

DeHart, Jason L. ;

Zimmerman, Erik S. ;

Ardon, Orly ;

Kim, Baek ;

Jacquot, Guillaume ;

Benichou, Serge ;

Planelles, Vicente .

PLOS PATHOGENS, 2006, 2 (12) :1106-1119

[2] Natural variation in HIV-1 protease, gag p7 and p6, and protease cleavage sites within Gag/Pol polyproteins: Amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1 [J].

Barrie, KA ;

Perez, E ;

Lamers, SL ;

Farmerie, WG ;

Dunn, BM ;

Sleasman, JW ;

Goodenow, MM .

VIROLOGY, 1996, 219 (02) :407-416

[3]

BATTULA N, 1976, J BIOL CHEM, V251, P982

[4] Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis [J].

Berthoux, L ;

Pechoux, C ;

Ottmann, M ;

Morel, G ;

Darlix, JL .

JOURNAL OF VIROLOGY, 1997, 71 (09) :6973-6981

[5]

Bloom G, 1998, ADV EXP MED BIOL, V436, P53

[6] Resistance of human immunodeficiency virus type 1 to protease inhibitors: Selection of resistance mutations in the presence and absence of the drug [J].

Borman, AM ;

Paulous, S ;

Clavel, F .

JOURNAL OF GENERAL VIROLOGY, 1996, 77 :419-426

[7] Associations between amino acids in the evolution of HIV type 1 protease sequences under indinavir therapy [J].

Brown, AJL ;

Korber, BT ;

Condra, JH .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (03) :247-253

[8] Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection [J].

Brown, AJL ;

Frost, SDW ;

Good, B ;

Daar, ES ;

Simon, V ;

Markowitz, M ;

Collier, AC ;

Connick, E ;

Conway, B ;

Margolick, JB ;

Routy, JP ;

Corbeil, J ;

Hellmann, NS ;

Richman, DD ;

Little, SJ .

JOURNAL OF VIROLOGY, 2004, 78 (05) :2242-2246

[9] Human immunodeficiency virus type 1 nucleocapsid Zn2+ fingers are required for efficient reverse transcription, initial integration processes, an protection of newly synthesized viral DNA [J].

Buckman, JS ;

Bosche, WJ ;

Gorelick, RJ .

JOURNAL OF VIROLOGY, 2003, 77 (02) :1469-1480

[10] APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC linker [J].

Burnett, Atuhani ;

Spearman, Paul .

JOURNAL OF VIROLOGY, 2007, 81 (10) :5000-5013

← 1 2 3 4 5 6 7 8 →